Literature DB >> 22474160

Contemporary aminophylline use for status asthmaticus in pediatric ICUs.

Abdallah Dalabih1, Zena Leah Harris2, Steven A Bondi2, Donald H Arnold3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474160      PMCID: PMC3318953          DOI: 10.1378/chest.11-2873

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Childhood asthma practice guideline part three: update of the 2007 National Guidelines for the Diagnosis and Treatment of Asthma. The National Asthma Education and Prevention Program.

Authors:  Nancy Cantey Banasiak
Journal:  J Pediatr Health Care       Date:  2009 Jan-Feb       Impact factor: 1.812

2.  Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.

Authors:  M W Weinberger; R A Matthay; E J Ginchansky; C A Chidsey; T L Petty
Journal:  JAMA       Date:  1976-05-10       Impact factor: 56.272

Review 3.  Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators.

Authors:  A Mitra; D Bassler; K Goodman; T J Lasserson; F M Ducharme
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 4.  Methylxanthines in asthma.

Authors:  Stephen L Tilley
Journal:  Handb Exp Pharmacol       Date:  2011
  4 in total
  2 in total

1.  Aminophylline infusion for status asthmaticus in the pediatric critical care unit setting is independently associated with increased length of stay and time for symptom improvement.

Authors:  Abdallah R Dalabih; Steven A Bondi; Zena L Harris; Benjamin R Saville; Wenli Wang; Donald H Arnold
Journal:  Pulm Pharmacol Ther       Date:  2013-03-19       Impact factor: 3.410

2.  Asthma changes at a pediatric intensive care unit after 10 years: Observational study.

Authors:  Ayman A Al-Eyadhy; Mohamad-Hani Temsah; Ali A N Alhaboob; Abdulmalik K Aldubayan; Nasser A Almousa; Abdulrahman M Alsharidah; Mohammed I Alangari; Abdulrahman M Alshaya
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.